TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
RCUS

Arcus Biosciences Inc

Healthcare · Biotechnology

26.40$ -1.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Arcus Biosciences Inc (RCUS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 924 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RCUS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,191 1,095 1,293 1,186 1,252 1,150 1,156 1,075 974 1,139 997 924
881 831 1,064 1,022 1,127 1,016 1,031 946 857 1,007 844 756
184 127 185 156 201 150 192 248 238 222 201 150
799 759 995 969 1,089 978 997 911 831 981 822 702
56 42 40 33 21 25 21 20 14 16 7.0 36
-207 – – – – – – – – – – –
50 – – – – – – – – – – –
671 633 586 551 687 665 625 526 538 508 473 460
200 184 204 199 215 226 192 210 235 231 209 198
9.0 11 11 11 11 12 12 12 13 13 13 13
17 17 16 15 13 18 22 29 42 42 39 34
– – – – 47 48 48 97 98 99 100 101
520 462 707 635 565 485 531 549 436 631 524 464
-768 -849 -853 -946 -1,038 -1,132 -1,244 -1,244 -1,379 -1,485 -1,613 -1,704
75 75 86 91 91 92 98 107 107 107 125 126

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?